These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8546165)

  • 41. Long-term results: cellulosic vs. synthetic membranes.
    Bonomini V; Colì L; Feliciangeli G; Mosconi G; Scolari MP
    Contrib Nephrol; 1995; 113():120-34. PubMed ID: 7712719
    [No Abstract]   [Full Text] [Related]  

  • 42. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biocompatibility and clinical performance of a new modified cellulose membrane.
    Bosch T; Schmidt B; Samtleben W; Gurland HJ
    Clin Nephrol; 1986; 26 Suppl 1():S22-9. PubMed ID: 3829464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule.
    Ronco C; Heifetz A; Fox K; Curtin C; Brendolan A; Gastaldon F; Crepaldi C; Fortunato A; Pietribasi G; Caberlotto A; Brunello A; Milan Manani S; Zanella M; La Greca G
    Int J Artif Organs; 1997 Mar; 20(3):136-43. PubMed ID: 9151148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 47. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
    Sulková S; Votruba T; Lapcík O; Válek A
    Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer.
    Woods HF
    ASAIO J; 2001; 47(5):573. PubMed ID: 11575841
    [No Abstract]   [Full Text] [Related]  

  • 49. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
    Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
    ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Activation of monocytes during hemodialysis].
    Stetsiuk EA; Osmolovskaia SV; Koval'chuk LV; Gankovskaia LV; Iarmolinskiĭ IS
    Ter Arkh; 1988; 60(6):57-60. PubMed ID: 3206372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthetic modification of PAN membrane: biocompatibility and functional characterization.
    Mujais SK; Schmidt B; Hacker H; Opatrny K; Gurland HJ
    Nephrol Dial Transplant; 1995; 10 Suppl 3():46-51. PubMed ID: 7494615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Granulocyte elastase, beta-thromboglobulin, and C3d during acetate or bicarbonate hemodialysis with Hemophan compared to a cellulose acetate membrane.
    Stegmayr BG; Esbensen K; Gutierrez A; Lundberg L; Nielsen B; Stroemsaeter CE; Wehle B
    Int J Artif Organs; 1992 Jan; 15(1):10-8. PubMed ID: 1532382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin 8 and biocompatibility of dialysis membranes.
    Niwa T; Miyazaki T; Sato M; Kambe F; Tsuzuki T; Uema K; Maeda K; Seo H
    Am J Nephrol; 1995; 15(3):181-5. PubMed ID: 7618641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K; Kobira S; Tomoyoshi T; Nishimura N
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes.
    Paczek L; Schaefer RM; Heidland A
    Nephron; 1990; 56(3):267-70. PubMed ID: 2077409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new polymethylmethacrylate membrane for hemodialysis.
    Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
    Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m).
    Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T
    ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta2-microglobulin and IgE release during hemodialysis with cuprophan membrane.
    Stefanović V; Savić V; Rajić M; Mitić-Zlatković M
    Int J Artif Organs; 1997 Dec; 20(12):713-4. PubMed ID: 9506789
    [No Abstract]   [Full Text] [Related]  

  • 59. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone.
    Amato M; Salvadori M; Bergesio F; Messeri A; Filimberti E; Morfini M
    Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
    García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.